Gedeon Richter PLC

BUSE:RICHTER Stock Report

Market Cap: Ft1.8t

Gedeon Richter Past Earnings Performance

Past criteria checks 3/6

Gedeon Richter has been growing earnings at an average annual rate of 17%, while the Pharmaceuticals industry saw earnings growing at 11.6% annually. Revenues have been growing at an average rate of 9.9% per year. Gedeon Richter's return on equity is 17%, and it has net margins of 25.2%.

Key information

17.03%

Earnings growth rate

17.48%

EPS growth rate

Pharmaceuticals Industry Growth12.39%
Revenue growth rate9.91%
Return on equity17.01%
Net Margin25.22%
Last Earnings Update30 Sep 2025

Recent past performance updates

Investors Shouldn't Be Too Comfortable With Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's (BUSE:RICHTER) Earnings

Apr 14
Investors Shouldn't Be Too Comfortable With Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's (BUSE:RICHTER) Earnings

Recent updates

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) Screens Well But There Might Be A Catch

Nov 06
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) Screens Well But There Might Be A Catch

The Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) Half-Yearly Results Are Out And Analysts Have Published New Forecasts

Aug 09
The Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) Half-Yearly Results Are Out And Analysts Have Published New Forecasts

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) Looks Inexpensive But Perhaps Not Attractive Enough

Jul 22
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) Looks Inexpensive But Perhaps Not Attractive Enough

These 4 Measures Indicate That Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Is Using Debt Reasonably Well

Jul 04
These 4 Measures Indicate That Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Is Using Debt Reasonably Well

Here's Why We Think Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Is Well Worth Watching

Jun 16
Here's Why We Think Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Is Well Worth Watching

Investors Shouldn't Be Too Comfortable With Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's (BUSE:RICHTER) Earnings

Apr 14
Investors Shouldn't Be Too Comfortable With Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's (BUSE:RICHTER) Earnings

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's (BUSE:RICHTER) Upcoming Dividend Will Be Larger Than Last Year's

Apr 11
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's (BUSE:RICHTER) Upcoming Dividend Will Be Larger Than Last Year's

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) Might Not Be As Mispriced As It Looks

Apr 09
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) Might Not Be As Mispriced As It Looks

We Think Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Can Manage Its Debt With Ease

Mar 22
We Think Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Can Manage Its Debt With Ease

Is There An Opportunity With Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s (BUSE:RICHTER) 45% Undervaluation?

Mar 04
Is There An Opportunity With Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s (BUSE:RICHTER) 45% Undervaluation?

Does Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Have A Healthy Balance Sheet?

Dec 05
Does Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (BUSE:RICHTER) Have A Healthy Balance Sheet?

Revenue & Expenses Breakdown

How Gedeon Richter makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BUSE:RICHTER Revenue, expenses and earnings (HUF Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 25901,323227,294232,71297,330
30 Jun 25903,361221,007231,535102,743
31 Mar 25878,137239,168228,090100,278
31 Dec 24857,545239,244220,93299,250
30 Sep 24839,601211,635207,70289,283
30 Jun 24811,415229,129203,42284,358
31 Mar 24798,937187,874199,58483,924
31 Dec 23805,158158,850196,61978,344
30 Sep 23825,94895,563201,66778,574
30 Jun 23855,211123,426199,70477,387
31 Mar 23844,351157,720191,46975,290
31 Dec 22802,755169,076182,35075,109
30 Sep 22755,061242,521165,81668,730
30 Jun 22694,772198,297155,13566,489
31 Mar 22657,758149,792146,77362,419
31 Dec 21630,595139,626143,26161,005
30 Sep 21604,708114,689139,57559,304
30 Jun 21584,88799,067136,05956,079
31 Mar 21566,244102,570132,52554,418
31 Dec 20566,776104,683133,76653,977
30 Sep 20555,12468,482134,35855,110
30 Jun 20544,96468,130137,59653,745
31 Mar 20527,60854,123144,86652,273
31 Dec 19507,79447,135145,28148,860
30 Sep 19490,66849,451144,04346,258
30 Jun 19462,57636,071143,72043,363
31 Mar 19453,15142,857141,65040,903
31 Dec 18445,48435,348139,65440,545
30 Sep 18434,07811,939140,52341,576
30 Jun 18441,99718,899139,25340,768
31 Mar 18445,6262,997139,41241,027
31 Dec 17444,3568,885138,25639,903
30 Sep 17439,82268,291137,88237,763
30 Jun 17429,20766,829136,12136,317
31 Mar 17413,02174,992131,93235,489
31 Dec 16389,69066,200127,90335,153
30 Sep 16372,68952,016122,48632,401
30 Jun 16368,53944,525120,79233,588
31 Mar 16366,88950,419118,31833,813
31 Dec 15365,22053,863117,70734,822
30 Sep 15366,63140,482117,11040,072
30 Jun 15362,90339,300119,71442,380
31 Mar 15353,08030,652119,71342,996
31 Dec 14353,70924,950121,31543,666

Quality Earnings: RICHTER has high quality earnings.

Growing Profit Margin: RICHTER's current net profit margins (25.2%) are higher than last year (25.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: RICHTER's earnings have grown by 17% per year over the past 5 years.

Accelerating Growth: RICHTER's earnings growth over the past year (7.4%) is below its 5-year average (17% per year).

Earnings vs Industry: RICHTER earnings growth over the past year (7.4%) did not outperform the Pharmaceuticals industry 8.9%.

Return on Equity

High ROE: RICHTER's Return on Equity (17%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/07 19:09
End of Day Share Price 2025/11/07 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Gedeon Richter PLC is covered by 20 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Simon MatherBarclays
Samuel EnglandBerenberg
Victoria LambertBerenberg